Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study.

MLA

Manfredi, Andreina, et al. “Tocilizumab Therapy in Rheumatoid Arthritis with Interstitial Lung Disease: A Multicentre Retrospective Study.” Internal Medicine Journal, vol. 50, no. 9, Sept. 2020, pp. 1085–90. EBSCOhost, https://doi.org/10.1111/imj.14670.

APA

Manfredi, A., Cassone, G., Furini, F., Gremese, E., Venerito, V., Atzeni, F., Arrigoni, E., Della Casa, G., Cerri, S., Govoni, M., Petricca, L., Iannone, F., Salvarani, C., & Sebastiani, M. (2020). Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study. Internal Medicine Journal, 50(9), 1085–1090. https://doi.org/10.1111/imj.14670

Chicago

Manfredi, Andreina, Giulia Cassone, Federica Furini, Elisa Gremese, Vincenzo Venerito, Fabiola Atzeni, Eugenio Arrigoni, et al. 2020. “Tocilizumab Therapy in Rheumatoid Arthritis with Interstitial Lung Disease: A Multicentre Retrospective Study.” Internal Medicine Journal 50 (9): 1085–90. doi:10.1111/imj.14670.